Nordion to divest targeted therapies business to BTG
May 27, 2013 | medicalphysicsweb.org
OTTAWA, ONTARIO, 23 May 2013 – Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced that it has entered into an agreement to divest...
Read more...
Nordion BTG TheraSphere divest therapy targeted